- Home
- PRGO vs OMCL Comparison
PRGO vs OMCL Comparison
Compare PRGO & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRGO | OMCL |
|---|---|---|
| Founded | 1887 | 1992 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2013 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PRGO | OMCL |
|---|---|---|
| Price | $14.76 | $33.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $19.33 | ★ $55.83 |
| AVG Volume (30 Days) | ★ 2.9M | 791.4K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | ★ 10.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | $800,000.00 | ★ $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | $1.02 | $5.22 |
| P/E Ratio | ★ N/A | $43.14 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $9.23 | $29.06 |
| 52 Week High | $23.98 | $51.84 |
Technical Indicators
Market Signals| Indicator | PRGO | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 73.63 | 31.22 |
| Support Level | $9.59 | $33.25 |
| Resistance Level | $15.08 | $35.62 |
| Average True Range (ATR) | 0.51 | 1.14 |
| MACD | 0.15 | -0.20 |
| Stochastic Oscillator | 97.18 | 7.93 |
Price Performance
Historical ComparisonAbout PRGO Perrigo Company plc
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.